These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Genetic deletion of low density lipoprotein receptor impairs sterol-induced mouse macrophage ABCA1 expression. A new SREBP1-dependent mechanism. Zhou X; He W; Huang Z; Gotto AM; Hajjar DP; Han J J Biol Chem; 2008 Jan; 283(4):2129-38. PubMed ID: 18029360 [TBL] [Abstract][Full Text] [Related]
4. Macrophage ABCG1 deletion disrupts lipid homeostasis in alveolar macrophages and moderately influences atherosclerotic lesion development in LDL receptor-deficient mice. Out R; Hoekstra M; Hildebrand RB; Kruit JK; Meurs I; Li Z; Kuipers F; Van Berkel TJ; Van Eck M Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2295-300. PubMed ID: 16857950 [TBL] [Abstract][Full Text] [Related]
5. Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice. Bogachev O; Majdalawieh A; Pan X; Zhang L; Ro HS Mol Med; 2011; 17(9-10):1056-64. PubMed ID: 21687917 [TBL] [Abstract][Full Text] [Related]
6. Independent protective roles for macrophage Abcg1 and Apoe in the atherosclerotic lesion development. Lammers B; Out R; Hildebrand RB; Quinn CM; Williamson D; Hoekstra M; Meurs I; Van Berkel TJ; Jessup W; Van Eck M Atherosclerosis; 2009 Aug; 205(2):420-6. PubMed ID: 19217108 [TBL] [Abstract][Full Text] [Related]
7. The effect of ABCG1 deficiency on atherosclerotic lesion development in LDL receptor knockout mice depends on the stage of atherogenesis. Meurs I; Lammers B; Zhao Y; Out R; Hildebrand RB; Hoekstra M; Van Berkel TJ; Van Eck M Atherosclerosis; 2012 Mar; 221(1):41-7. PubMed ID: 22196936 [TBL] [Abstract][Full Text] [Related]
8. Deficiency of ATP-Binding Cassette Transporters A1 and G1 in Endothelial Cells Accelerates Atherosclerosis in Mice. Westerterp M; Tsuchiya K; Tattersall IW; Fotakis P; Bochem AE; Molusky MM; Ntonga V; Abramowicz S; Parks JS; Welch CL; Kitajewski J; Accili D; Tall AR Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1328-37. PubMed ID: 27199450 [TBL] [Abstract][Full Text] [Related]
10. Decreased atherosclerosis in low-density lipoprotein receptor knockout mice transplanted with Abcg1-/- bone marrow. Ranalletta M; Wang N; Han S; Yvan-Charvet L; Welch C; Tall AR Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2308-15. PubMed ID: 16917103 [TBL] [Abstract][Full Text] [Related]
11. Dietary phytosterol does not accumulate in the arterial wall and prevents atherosclerosis of LDLr-KO mice. Bombo RP; Afonso MS; Machado RM; Lavrador MS; Nunes VS; Quintão ER; Koike M; Catanozi S; Lin CJ; Nakandakare ER; Lottenberg AM Atherosclerosis; 2013 Dec; 231(2):442-7. PubMed ID: 24267264 [TBL] [Abstract][Full Text] [Related]
12. Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions. Yvan-Charvet L; Welch C; Pagler TA; Ranalletta M; Lamkanfi M; Han S; Ishibashi M; Li R; Wang N; Tall AR Circulation; 2008 Oct; 118(18):1837-47. PubMed ID: 18852364 [TBL] [Abstract][Full Text] [Related]
13. Leukocyte ABCA1 remains atheroprotective in splenectomized LDL receptor knockout mice. Lammers B; Zhao Y; Foks AC; Hildebrand RB; Kuiper J; Van Berkel TJ; Van Eck M PLoS One; 2012; 7(10):e48080. PubMed ID: 23133551 [TBL] [Abstract][Full Text] [Related]
14. Advanced oxidation protein products exacerbates lipid accumulation and atherosclerosis through downregulation of ATP-binding cassette transporter A1 and G1 expression in apolipoprotein E knockout mice. Mo ZC; Xiao J; Tang SL; Ouyang XP; He PP; Lv YC; Long ZF; Yao F; Tan YL; Xie W; Zhang M; Liu D; Tian GP; Tang DP; Zheng XL; Zhao GJ; Tang CK Circ J; 2014; 78(11):2760-70. PubMed ID: 25262842 [TBL] [Abstract][Full Text] [Related]
15. Cholesterol reduction and atherosclerosis inhibition by bezafibrate in low-density lipoprotein receptor knockout mice. Inaba T; Yagyu H; Itabashi N; Tazoe F; Fujita N; Nagashima S; Okada K; Okazaki M; Furukawa Y; Ishibashi S Hypertens Res; 2008 May; 31(5):999-1005. PubMed ID: 18712055 [TBL] [Abstract][Full Text] [Related]
16. Combined deletion of macrophage ABCA1 and ABCG1 leads to massive lipid accumulation in tissue macrophages and distinct atherosclerosis at relatively low plasma cholesterol levels. Out R; Hoekstra M; Habets K; Meurs I; de Waard V; Hildebrand RB; Wang Y; Chimini G; Kuiper J; Van Berkel TJ; Van Eck M Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):258-64. PubMed ID: 18006857 [TBL] [Abstract][Full Text] [Related]
17. EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions. Marleau S; Harb D; Bujold K; Avallone R; Iken K; Wang Y; Demers A; Sirois MG; Febbraio M; Silverstein RL; Tremblay A; Ong H FASEB J; 2005 Nov; 19(13):1869-71. PubMed ID: 16123174 [TBL] [Abstract][Full Text] [Related]
18. Liver ABCA1 deletion in LDLrKO mice does not impair macrophage reverse cholesterol transport or exacerbate atherogenesis. Bi X; Zhu X; Duong M; Boudyguina EY; Wilson MD; Gebre AK; Parks JS Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2288-96. PubMed ID: 23814116 [TBL] [Abstract][Full Text] [Related]
19. Hepatic ABCG5 and ABCG8 overexpression increases hepatobiliary sterol transport but does not alter aortic atherosclerosis in transgenic mice. Wu JE; Basso F; Shamburek RD; Amar MJ; Vaisman B; Szakacs G; Joyce C; Tansey T; Freeman L; Paigen BJ; Thomas F; Brewer HB; Santamarina-Fojo S J Biol Chem; 2004 May; 279(22):22913-25. PubMed ID: 15044450 [TBL] [Abstract][Full Text] [Related]
20. Impaired development of atherosclerosis in hyperlipidemic Ldlr-/- and ApoE-/- mice transplanted with Abcg1-/- bone marrow. Baldán A; Pei L; Lee R; Tarr P; Tangirala RK; Weinstein MM; Frank J; Li AC; Tontonoz P; Edwards PA Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2301-7. PubMed ID: 16888235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]